CopyMark Law Group
4.9/5
Drawing for RELIEF IS IN SIGHT

USPTO serial 98107083

RELIEF IS IN SIGHT

Reviewed by CopyMark Law Group

Reg. 7666558Status 700Registered
Filing date
Status date
Registration date
Jan 28, 2025
Examiner
NGUYEN, CINDY EVANS
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RELIEF IS IN SIGHT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Chelsea E. Carbone

Chelsea E. Carbone WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304-1050United States

Goods and services

ClassDescriptionStatusFirst use
009Lenses for eyeglasses; spectacle lenses with prism; contoured prism eyeglass lenses to alleviate symptoms of misalignment and to provide relief for hard-working eyes; lenses for eyeglasses to relieve symptoms of eyestrain resulting from use of digital devices; eyeglasses to relieve the symptoms of eye fatigue, headaches, neck pain, and shoulder pain; computer eye glasses; digital eye glasses; eyeglasses with progressive prism; eyeglasses to treat trigeminal dysphoria; progressive eyeglass lenses with contour prismACTIVE—
010Diagnostic apparatus for diagnosing eye diseases and dysfunctions for medical use; optometric instruments for determining eye misalignment and vergence insufficiency; apparatus to diagnose strabismus for prism to be implemented in spectacle lenses for medical purposes; apparatus for measuring and diagnosing strabismus, trigeminal dysphoria, vergence insufficiency and ocular misalignment in order to determine prescription for contoured prism eyeglass lenses to alleviate symptoms of misalignment and to provide relief for hard-working eyes for medical purposes; apparatus for measuring and diagnosing strabismus, trigeminal dysphoria and ocular misalignment in order to determine lens prescription for eyeglasses to relieve symptoms of eyestrain resulting from use of digital devices for medical purposes; apparatus for measuring and diagnosing strabismus, trigeminal dysphoria, vergence insufficiency and ocular misalignment in order to determine eyeglass prescription to relieve the symptoms of eye fatigue, headaches, neck pain, and shoulder pain for medical purposes; optometric measurement instrument to determine prescription for computer glasses and digital glasses prism by measuring ocular misalignment for medical purposes; apparatus for measuring and diagnosing trigeminal dysphoria in order to determine lens prescription to treat trigeminal dysphoria for medical purposes; optometric measurement instrument to assist the prescription of contact lenses with prism and contour prism by measuring ocular misalignment for medical purposes; optometric instrument for measuring ocular motility for medical purposes; optometric instrument for pupillometry for medical purposes; optometric instrument for measuring afferent pupillary response for medical purposes; optometric instrument for assessing saccadic eye movement for medical purposes; optometric instrument for measuring smooth pursuits of the eye for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 8, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 27, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 27, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 27, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 28, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 28, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 10, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 10, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 4, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 14, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 13, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 13, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 13, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 31, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 31, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 31, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 10, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 10, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 10, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 3, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 3, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 10, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2024DOCKASSIGNED TO EXAMINER—
Aug 28, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 1, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance